BioXcel Therapeutics
BTAI
#9512
Rank
HK$0.21 B
Marketcap
HK$5.17
Share price
3.12%
Change (1 day)
-86.21%
Change (1 year)

BioXcel Therapeutics (BTAI) - P/B ratio

P/B ratio as of November 2024 : -0.3620

According to BioXcel Therapeutics's latest financial reports the company has a price-to-book ratio of 11.1939.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioXcel Therapeutics - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-1.53-119.49%
2022-12-317.84205.53%
2021-12-312.57-52.98%
2020-12-315.46-44.45%
2019-12-319.83531.99%
2018-12-311.55
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.13-689.59%๐Ÿ‡บ๐Ÿ‡ธ USA